Evidence map›Paper›PMID 23375640›Full record

Trial reportPsychoneuroendocrinology2013

Reduction in salivary α-amylase levels following a mind-body intervention in cancer survivors--an exploratory study.

David L Lipschitz, Renee Kuhn, Anita Y Kinney, Gary W Donaldson, Yoshio Nakamura

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychoneuroendocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2016
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Salivary Alpha-Amylase as a Biomarker of Stress in Behavioral Medicine.International journal of behavioral medicine · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David L LipschitzUtah Center for Exploring Mind-Body Interactions (UCEMBI), Pain Research Center, Department of Anesthesiology, University of Utah School of Medicine, United States; Pain Research Center, Department of Anesthesiology, University of Utah School of Medicine, United States. Electronic address: david.lipschitz@utah.edu.
Renee Kuhn
Anita Y Kinney
Gary W Donaldson
Yoshio Nakamura
University of Utah · US

Funding

Utah Center for Exploring Mind-Body Interactions (UCEMB*R21AT002209 · NCCIH · UNIVERSITY OF UTAH · PI NAKAMURA, YOSHIO · 2004 to 2006
$1.3M
NCCIH NIH HHS R21 AT002209
6 · The paper itself

Abstract

objectiveThe main aim of this exploratory study was to assess whether salivary α-amylase (sAA) and salivary cortisol levels would be positively modulated by sleep-focused mind-body interventions in female and male cancer survivors.

methodsWe conducted a randomized controlled trial in which 57 cancer survivors with self-reported sleep disturbance received either a Sleep Hygiene Education (SHE; n=18) control, or one of two experimental mind-body interventions, namely, Mind-Body Bridging (MBB; n=19) or Mindfulness Meditation (MM; n=20). Interventions were three sessions each conducted once per week for three consecutive weeks. Saliva cortisol and sAA were measured at baseline and 1 week after the last session. Participants also completed a sleep scale at the same time points when saliva was collected for biomarker measurement.

resultsOur study revealed that at post-intervention assessment, mean sAA levels upon awakening ("Waking" sample) declined in MBB compared with that of SHE. Mean Waking cortisol levels did not differ among treatment groups but declined slightly in SHE. Self-reported sleep improved across the three interventions at Post-assessment, with largest improvements in the MBB intervention.

conclusionIn this exploratory study, sleep focused mind-body intervention (MBB) attenuated Waking sAA levels, suggesting positive influences of a mind-body intervention on sympathetic activity in cancer survivors with sleep disturbance.

Indexed as

Mind-Body TherapiesAdolescentAdultAgedBiomarkersDyssomniasFemaleHumansHydrocortisoneMaleMeditationMiddle AgedMindfulnessNeoplasmsPatient Education as TopicPsychophysiologyBiomarkersHydrocortisoneSalivary alpha-AmylasesBiomarkerCancer survivorMind–body interventionSalivary cortisolSalivary α-amylaseSleep disturbanceStressSympathetic nervous system

Identifiers

PMID23375640
PMCPMC3686861
OpenAlexW2172280496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.